Mitochondria: A Therapeutic Target in Neurodegeneration - Archive ouverte HAL Access content directly
Journal Articles Biochimica et Biophysica Acta - Molecular Basis of Disease Year : 2009

Mitochondria: A Therapeutic Target in Neurodegeneration

Abstract

Mitochondrial dysfunction has long been associated with neurodegenerative disease. Therefore, mitochondrial protective agents represent a unique direction for the development of drug candidates that can modify the pathogenesis of neurodegeneration. This review discusses evidence showing that mitochondrial dysfunction has a central role in the pathogenesis of Alzheimer's, Parkinson's and Huntington's diseases and amyotrophic lateral sclerosis. We also debate the potential therapeutic efficacy of metabolic antioxidants, mitochondria-directed antioxidants and Szeto-Schiller (SS) peptides. Since these compounds preferentially target mitochondria, a major source of oxidative damage, they are promising therapeutic candidates for neurodegenerative diseases. Furthermore, we will briefly discuss the novel action of the antihistamine drug Dimebon on mitochondria.
Fichier principal
Vignette du fichier
PEER_stage2_10.1016%2Fj.bbadis.2009.10.007.pdf (320.35 Ko) Télécharger le fichier
Origin : Files produced by the author(s)
Loading...

Dates and versions

hal-00562943 , version 1 (04-02-2011)

Identifiers

Cite

Paula I. Moreira, Xiongwei Zhu, Xinglong Wang, Hyoung-Gon Lee, Akihiko Nunomura, et al.. Mitochondria: A Therapeutic Target in Neurodegeneration. Biochimica et Biophysica Acta - Molecular Basis of Disease, 2009, 1802 (1), pp.212. ⟨10.1016/j.bbadis.2009.10.007⟩. ⟨hal-00562943⟩

Collections

PEER
53 View
99 Download

Altmetric

Share

Gmail Facebook X LinkedIn More